Moleculin Biotech, Inc. (MBRX)
2.23
-0.06
(-2.62%)
USD |
NASDAQ |
Apr 01, 16:00
2.19
-0.04
(-1.79%)
Pre-Market: 09:25
Moleculin Biotech Shareholders Equity (Quarterly) : 15.01M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Imunon, Inc. | 7.062M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.13M |
| Total Liabilities (Quarterly) | 7.12M |
| Debt to Equity Ratio | 0.0239 |
| Current Ratio | 1.413 |
| Net Debt Paydown Yield | 0.35% |